Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
Rob23460 to be fair to FUM I think it’s out of their hands to a degree as they handed the distribution rights to Cooper healthcare. The onus will be on Cooper to smooth out any supply chain issues but clearly FUM do have a duty to explain things to shareholders.
Thanks for posting this oldtramp. If the QVH CDC becomes a blueprint for the other CDC’s across the country would be a game changer for FDBK and the sp.
Does anyone know if the tenders for the 100 plus CDC’s will be publicised publicly when they arise or is it a closed bid system?
And also with the South West tender which you would think will be decided upon by latest end of next week.
Latest eroxon website to pop up with clinical data and poster presented by Professor Ralph
https://hcp.eroxon.co.uk/
FUM have clearly stated they expect a decision by end of Q1 2023 so while I’m not holding my breath for the 150 day timescale I’m expecting something by end of March. They would have been advised by FDA on this timescale hence the confidence in putting a date in an RNS.
Interesting Tweet highlighting 19 new CDC's with Youtube link explaining Bleepa in CDC settings
https://twitter.com/BleepaMe/status/1628330052327813121?s=20
It’s interesting Vascular predicted there’d be some large buys before good news comes in before he went away. To be a fly on the wall at Feedback HQ atm!
What intrigues me is how the buyer found so many shares. Perhaps some inside track information for this buyer.
Can you imagine the value of the company if Bleepa gets rolled out across the NHS via exemplar program. Tom’s share option targets will be smashed.